BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 31243362)

  • 1. Immune evasion before tumour invasion in early lung squamous carcinogenesis.
    Mascaux C; Angelova M; Vasaturo A; Beane J; Hijazi K; Anthoine G; Buttard B; Rothe F; Willard-Gallo K; Haller A; Ninane V; Burny A; Sculier JP; Spira A; Galon J
    Nature; 2019 Jul; 571(7766):570-575. PubMed ID: 31243362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune landscape during the tumorigenesis of cervical cancer.
    Wang Y; He M; Zhang G; Cao K; Yang M; Zhang H; Liu H
    Cancer Med; 2021 Apr; 10(7):2380-2395. PubMed ID: 33694292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.
    Dejima H; Hu X; Chen R; Zhang J; Fujimoto J; Parra ER; Haymaker C; Hubert SM; Duose D; Solis LM; Su D; Fukuoka J; Tabata K; Pham HHN; Mcgranahan N; Zhang B; Ye J; Ying L; Little L; Gumbs C; Chow CW; Estecio MR; Godoy MCB; Antonoff MB; Sepesi B; Pass HI; Behrens C; Zhang J; Vaporciyan AA; Heymach JV; Scheet P; Lee JJ; Wu J; Futreal PA; Reuben A; Kadara H; Wistuba II; Zhang J
    Nat Commun; 2021 May; 12(1):2722. PubMed ID: 33976164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untangling the evolutionary roots of lung cancer.
    Devarakonda S; Govindan R
    Nat Commun; 2019 Jul; 10(1):2979. PubMed ID: 31278259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoantigen-directed immune escape in lung cancer evolution.
    Rosenthal R; Cadieux EL; Salgado R; Bakir MA; Moore DA; Hiley CT; Lund T; Tanić M; Reading JL; Joshi K; Henry JY; Ghorani E; Wilson GA; Birkbak NJ; Jamal-Hanjani M; Veeriah S; Szallasi Z; Loi S; Hellmann MD; Feber A; Chain B; Herrero J; Quezada SA; Demeulemeester J; Van Loo P; Beck S; McGranahan N; Swanton C;
    Nature; 2019 Mar; 567(7749):479-485. PubMed ID: 30894752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evasion before invasion: Pre-cancer immunosurveillance.
    Angelova M; Mascaux C; Galon J
    Oncoimmunology; 2021 Apr; 10(1):1912250. PubMed ID: 33996263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis.
    Ooi AT; Gower AC; Zhang KX; Vick JL; Hong L; Nagao B; Wallace WD; Elashoff DA; Walser TC; Dubinett SM; Pellegrini M; Lenburg ME; Spira A; Gomperts BN
    Cancer Prev Res (Phila); 2014 May; 7(5):487-95. PubMed ID: 24618292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune subgroup analysis for non-small cell lung cancer may be a good choice for evaluating therapeutic efficacy and prognosis.
    Tian Y; Wang J; Wen Q; Su G; Sun Y
    Aging (Albany NY); 2021 May; 13(9):12691-12709. PubMed ID: 33973529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC.
    Tian Y; Zhai X; Yan W; Zhu H; Yu J
    Cancer Med; 2021 Jan; 10(1):3-14. PubMed ID: 33230935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of deltaNp63(pos)CD44v(pos) cells in the development of N-nitroso-tris-chloroethylurea-induced peripheral-type mouse lung squamous cell carcinomas.
    Yamano S; Gi M; Tago Y; Doi K; Okada S; Hirayama Y; Tachibana H; Ishii N; Fujioka M; Tatsumi K; Wanibuchi H
    Cancer Sci; 2016 Feb; 107(2):123-32. PubMed ID: 26663681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the genesis of bronchial epidermoid carcinoma: evolution or the expression of proteins, messenger RNAs and microRNAs at all stages of the process of carcinogenesis].
    Mascaux C
    Bull Mem Acad R Med Belg; 2009; 164(5-6):247-54. PubMed ID: 20666154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells.
    Casanova-Acebes M; Dalla E; Leader AM; LeBerichel J; Nikolic J; Morales BM; Brown M; Chang C; Troncoso L; Chen ST; Sastre-Perona A; Park MD; Tabachnikova A; Dhainaut M; Hamon P; Maier B; Sawai CM; Agulló-Pascual E; Schober M; Brown BD; Reizis B; Marron T; Kenigsberg E; Moussion C; Benaroch P; Aguirre-Ghiso JA; Merad M
    Nature; 2021 Jul; 595(7868):578-584. PubMed ID: 34135508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response and evasion mechanisms in lip carcinogenesis: An immunohistochemical study.
    Lopes MLDS; Gonzaga AKG; Mosconi C; Palomino GM; Mendonça EF; Batista AC; Silveira ÉJDD
    Arch Oral Biol; 2019 Feb; 98():99-107. PubMed ID: 30468994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma.
    Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M
    Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer.
    Pennycuick A; Teixeira VH; AbdulJabbar K; Raza SEA; Lund T; Akarca AU; Rosenthal R; Kalinke L; Chandrasekharan DP; Pipinikas CP; Lee-Six H; Hynds RE; Gowers KHC; Henry JY; Millar FR; Hagos YB; Denais C; Falzon M; Moore DA; Antoniou S; Durrenberger PF; Furness AJ; Carroll B; Marceaux C; Asselin-Labat ML; Larson W; Betts C; Coussens LM; Thakrar RM; George J; Swanton C; Thirlwell C; Campbell PJ; Marafioti T; Yuan Y; Quezada SA; McGranahan N; Janes SM
    Cancer Discov; 2020 Oct; 10(10):1489-1499. PubMed ID: 32690541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions.
    Teixeira VH; Pipinikas CP; Pennycuick A; Lee-Six H; Chandrasekharan D; Beane J; Morris TJ; Karpathakis A; Feber A; Breeze CE; Ntolios P; Hynds RE; Falzon M; Capitanio A; Carroll B; Durrenberger PF; Hardavella G; Brown JM; Lynch AG; Farmery H; Paul DS; Chambers RC; McGranahan N; Navani N; Thakrar RM; Swanton C; Beck S; George PJ; Spira A; Campbell PJ; Thirlwell C; Janes SM
    Nat Med; 2019 Mar; 25(3):517-525. PubMed ID: 30664780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of chromosomal abnormalities at 1p36 and 9p21 in early-stage central type squamous cell carcinoma and squamous dysplasia of bronchus detected by autofluorescence bronchoscopy.
    Shibukawa K; Miyokawa N; Tokusashi Y; Sasaki T; Osanai S; Ohsaki Y
    Oncol Rep; 2009 Jul; 22(1):81-7. PubMed ID: 19513508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA highly up-regulated in liver cancer promotes epithelial-to-mesenchymal transition process in oral squamous cell carcinoma.
    Su W; Tang J; Wang Y; Sun S; Shen Y; Yang H
    J Cell Mol Med; 2019 Apr; 23(4):2645-2655. PubMed ID: 30677230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment.
    Hirai M; Kitahara H; Kobayashi Y; Kato K; Bou-Gharios G; Nakamura H; Kawashiri S
    Int J Oncol; 2017 Jan; 50(1):41-48. PubMed ID: 27922697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.